These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 32407843)
1. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker. Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843 [TBL] [Abstract][Full Text] [Related]
2. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer. Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B Gene; 2021 Mar; 772():145376. PubMed ID: 33359128 [TBL] [Abstract][Full Text] [Related]
3. ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis. Bidar N; Rezaei T; Amini M; Jebelli A; Mokhtarzadeh A; Baradaran B Exp Mol Pathol; 2021 Aug; 121():104663. PubMed ID: 34171355 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis. Hu G; Qin L; Zhang X; Ye G; Huang T Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683 [TBL] [Abstract][Full Text] [Related]
5. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia. Chen X; Lin Z; Xue M; Si J; Chen S PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array. Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985 [TBL] [Abstract][Full Text] [Related]
7. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer. Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573 [TBL] [Abstract][Full Text] [Related]
8. A methylation-driven gene panel predicts survival in patients with colon cancer. Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409 [TBL] [Abstract][Full Text] [Related]
9. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Zhou C; Pan R; Li B; Huang T; Zhao J; Ying J; Duan S Future Oncol; 2019 Apr; 15(11):1279-1289. PubMed ID: 30924352 [TBL] [Abstract][Full Text] [Related]
10. Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer. Ling ZQ; Lv P; Lu XX; Yu JL; Han J; Ying LS; Zhu X; Zhu WY; Fang XH; Wang S; Wu YC PLoS One; 2013; 8(6):e67195. PubMed ID: 23826230 [TBL] [Abstract][Full Text] [Related]
11. Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers. Dai X; Sun X; Wu Y; Lv Z; Yu Z; Yuan Y; Sun L Dis Markers; 2022; 2022():4570290. PubMed ID: 35242243 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment. Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer. Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004 [TBL] [Abstract][Full Text] [Related]
14. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer. Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261 [TBL] [Abstract][Full Text] [Related]
15. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer. Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488 [TBL] [Abstract][Full Text] [Related]
17. DERL3 functions as a tumor suppressor in gastric cancer. Li Y; Liu H; Chen H; Shao J; Su F; Zhang S; Cai X; He X Comput Biol Chem; 2020 Feb; 84():107172. PubMed ID: 31862624 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368 [TBL] [Abstract][Full Text] [Related]
19. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population. Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954 [TBL] [Abstract][Full Text] [Related]
20. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium]. Cai JC; Liu D; Zhang HP; Zhong S; Xia NS Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]